![A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy | Leukemia A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-020-01059-3/MediaObjects/41375_2020_1059_Fig1_HTML.png)
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy | Leukemia
![PDF) A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy PDF) A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy](https://i1.rgstatic.net/publication/345600644_A_multicenter_prospective_randomized_placebo-controlled_phase_IIIII_trial_for_preemptive_acute_graft-versus-host_disease_therapy/links/5fb26348299bf10c3683692f/largepreview.png)
PDF) A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy
![The Multicentre, Double-Blinded, Placebo-Controlled Clinical-Trial (Pre-GvHD) for Prediction and Pre-Emptive Treatment of Acute GvHD - ScienceDirect The Multicentre, Double-Blinded, Placebo-Controlled Clinical-Trial (Pre-GvHD) for Prediction and Pre-Emptive Treatment of Acute GvHD - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497119810297-gr1.jpg)